BioLineRx Ltd’s (NASDAQ:BLRX) poster, which includes new data from the single-arm pilot phase of the investigator-initiated, randomized CheMo4METPANC Phase 2 combination trial, will be presented at ...

Exosomes transform prostate cancer care with early detection, tailored treatments, and real-time prognosis tracking for ...

One year after becoming the first centre to open a global clinical trial of a radioligand therapy for metastatic prostate ...

Genetic testing for hereditary cancer unexpectedly uncovered a case of myelodysplastic syndrome (MDS), highlighting the need ...

A new study employing novel single-cell multimodal data revealed key insights into the tumor microenvironment predictive of NSCLC treatment response.

New tools, treatment options, and precision medicine developments are leading to better quality of life and survival for ...

Researchers found that the Wnt5a protein, secreted by inflammatory fibroblasts within cancerous tumors, inhibits angiogenesis and consequently promotes hypoxia within tumors. Hypoxic conditions help ...

Researchers led by Université de Montréal pathology and cell-biology professor Marc Therrien have identified major structural ...

A lab-designed molecule developed and extensively studied could represent a breakthrough in slowing tumor recurrence in glioblastoma, an aggressive and deadly form of brain cancer.

A lab-designed molecule developed and extensively studied by scientists with Virginia Tech's Fralin Biomedical Research ...

Discover how stem cells may help reduce acne scars by boosting collagen, improving skin texture, and speeding up healing—plus ...